Lenire Champions Veterans' Hearing Health Through Hearoes Tour
Lenire takes a bold step in supporting veterans by sponsoring the 10th Annual LexCare Hearing Foundation Hearoes Tour. This initiative is tailored to bring critical awareness and accessible care for veterans grappling with tinnitus, a prevalent affliction among those who have served in the military.
About the Hearoes Tour
The Hearoes Tour is more than just a series of events; it's a national movement committed to providing invaluable hearing health resources and screenings. Annually, the tour facilitates over 200 events that reach out to veteran communities across the nation, effectively breaking down the barriers to accessing tinnitus care and ensuring that veterans receive the support they need.
Impact on Veterans
According to reports, nearly 40% of the veterans served through the Hearoes Tour have experienced tinnitus, highlighting the pressing need for effective treatment options. Jaime Motes, founder and director of the LexCare Hearing Foundation, shared her motivation for championing this cause. She emphasizes the importance of finding solutions for veterans who have long faced this debilitating condition.
A Personal Connection
Motes's connection to the mission is deeply personal, drawing from her experience as a parent of a child with cochlear implants. She passionately believes that every veteran deserves options for their hearing health, reflecting a commitment that goes beyond words—it's about advocacy, awareness, and action.
Tinnitus: A Critical Issue for Veterans
Tinnitus, identified as the number one service-connected disability, has been a significant concern for veterans seeking compensation from the VA. Recent estimates suggest that in one year alone, veterans received approximately $6.6 billion for tinnitus-related claims. This staggering figure emphasizes the urgency of addressing this issue effectively.
Neuromod's Role in Tinnitus Care
With Neuromod leading the charge, Lenire has emerged as a groundbreaking solution for veterans affected by tinnitus, having received FDA Approval as the first bimodal neuromodulation device. Recently awarded a Federal Supply Schedule (FSS) Contract, Lenire is now available to over 3.2 million veterans through the Department of Veterans Affairs, a significant leap forward in making effective tinnitus treatment accessible.
The Future of Hearing Care
The collaboration between Lenire and the LexCare Hearing Foundation represents a pivotal moment in the pursuit of effective treatment solutions for tinnitus. Eric Timm, the CEO of Neuromod USA, underscores the importance of this partnership, which reinforces their dedication to veterans and elevates awareness about the significance of proactive hearing health treatment.
Evidence from independent clinics indicates that Lenire is not just a theoretical solution; its real-world effectiveness is evidenced by a 91.5% improvement reported by over 220 patients at the Alaska Hearing & Tinnitus Center. This aligns with findings from previous clinical trials, reinforcing the potential of Lenire to change lives significantly.
Clinical Validation and Continued Research
Lenire's pivotal controlled clinical trial results significantly contributed to its FDA approval. Featured prominently in a leading peer-reviewed journal, this research reminds us of the importance of continued inquiry and validation as we strive to meet the needs of those who suffer from tinnitus.
About Neuromod
Founded in 2010, Neuromod Devices Ltd., with its headquarters in Dublin, Ireland, is at the forefront of developing neuromodulation technologies. Their mission is to address severe chronic conditions impacting patient quality of life, such as tinnitus. Lenire exemplifies their commitment, providing a non-invasive treatment option that integrates auditory stimulation with neuromodulation.
Understanding Tinnitus
Tinnitus, often characterized by a persistent ringing in the ears, affects approximately 15% of adults globally. It presents a unique challenge to individuals, often leading to discomfort and impaired quality of life. Lenire provides hope by offering a scientifically-backed solution.
The Journey Ahead
Lenire is dedicated to transforming how we approach hearing and tinnitus disorders. By combining cutting-edge technology with compassionate outreach, Lenire seeks to remove barriers veterans face in accessing care. With ongoing efforts and innovative partnerships, the future of veterans' hearing health is more promising than ever.
Frequently Asked Questions
What is the Hearoes Tour?
The Hearoes Tour is a nationwide initiative aimed at providing resources, screenings, and support for veterans suffering from hearing issues and tinnitus.
Why is tinnitus significant for veterans?
Tinnitus is the number one service-connected disability among veterans, impacting their lives significantly and leading to substantial compensation claims.
How does Lenire help with tinnitus?
Lenire uses a non-invasive bimodal neuromodulation approach, combining auditory stimulation with electrical pulses to help alleviate tinnitus symptoms.
Who can access Lenire's treatment?
Lenire is available to 3.2 million veterans through the Department of Veterans Affairs, ensuring that treatment is accessible to those in need.
What sets Lenire apart from other treatments?
Lenire is the first FDA-approved bimodal neuromodulation device, showcasing a commitment to innovative and effective solutions for tinnitus.
